Hanmi Science Co (008930.KS) Hisse Fiyat
Hanmi Science Co Fiyat
Gelir, son 19 yılda yıllık bileşik %6,0 artarak 1,36 T KRW seviyesine ulaştı. Hisse başına kâr, son 19 yılda yıllık %2,6 büyüdü. Hanmi Science Co şirketinde net marj %8,7 seviyesinde bulunuyor; birkaç yıl önceki %4,5 seviyesine göre yükseldi. Hanmi Science Co şu anda yaklaşık %0,66 temettü verimi sunuyor. Temettü dağıtım oranı, kârın yaklaşık %32 düzeyindedir.
Hanmi Science Co hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Hanmi Science Co iş modeli ve hisse analizi
Hanmi Science Co hakkında sık sorulan sorular
The business model of Hanmi Science Co Ltd., a South Korean company, revolves around its expertise in the field of biotechnology. Hanmi Science focuses on the development, manufacturing, and distribution of innovative pharmaceutical products. The company is committed to researching and creating cutting-edge drugs and therapies to address various medical conditions and improve patient outcomes. With a strong emphasis on research and development, Hanmi Science aims to enhance global healthcare by delivering novel treatment options to customers worldwide.
Hanmi Science Co Ltd is primarily active in the pharmaceutical and healthcare industries.
Hanmi Science Co Ltd faces competition from various companies in the market. Some of its main competitors include CJ Healthcare Corp, SK Biopharmaceuticals Co Ltd, and Yuhan Corporation. These competitors are also prominent players in the pharmaceutical and biotechnology industry.
Hanmi Science Co Ltd is a leading company in the healthcare industry. Established in 1973, Hanmi Science Co Ltd has a rich history of over four decades. The company focuses on research, development, and manufacturing of innovative medical devices and pharmaceutical products. With a strong commitment to improving global healthcare, Hanmi Science Co Ltd has made significant contributions to the industry. They have formed strategic partnerships and collaborations with renowned companies to enhance their capabilities and expand their global presence. Hanmi Science Co Ltd's dedication to quality, innovation, and customer satisfaction has positioned them as a trusted and reliable name in the healthcare sector.
Hanmi Science Co Ltd has achieved several significant milestones in its corporate history. The company made its debut in 1973 as a small chemical trading business and has since evolved into a leading global provider of pharmaceutical and healthcare solutions. Hanmi Science Co Ltd successfully developed and launched its first original drug, LUSEDRA, in 2008, marking a major advancement in the pharmaceutical sector. Additionally, the company has established numerous strategic partnerships and collaborations with global pharmaceutical giants, enabling it to enhance its research and development capabilities. Hanmi Science Co Ltd continues to foster innovation, expand its product pipeline, and deliver breakthrough treatments to improve patient outcomes.
Hanmi Science Co Ltd is primarily present in South Korea.
Hanmi Science Co Ltd represents values of innovation, excellence, and customer satisfaction. With a strong corporate philosophy focused on pioneering new technologies and providing top-notch services, Hanmi Science Co Ltd aims to meet the ever-evolving needs of its clients. By prioritizing research and development, the company strives to deliver cutting-edge solutions in the fields of biotechnology and pharmaceuticals. With a commitment to ethical practices, Hanmi Science Co Ltd also emphasizes integrity and social responsibility in its operations. Through its dedication to these values and its forward-thinking approach, Hanmi Science Co Ltd continues to make significant contributions to the industry.
Güncel döviz kuruyla Hanmi Science Co hissesi 30,51 EUR (45.550,00 KRW) seviyesindedir.
Hanmi Science Co hissesi (008930.KS) 1 borsada işlem görür, bunlar arasında: KOSPI (Seoul) (008930.KS).
Hanmi Science Co Ltd is a leading company in the pharmaceutical industry that specializes in the research and development of innovative drugs and medical devices. The company offers a wide range of products and services divided into various business areas.
Hasılat Hanmi Science Co için şu anda hesaplanamaz.
Kar Hanmi Science Co için şu anda hesaplanamaz.
F/K oranı Hanmi Science Co için şu anda hesaplanamaz.
F/S Hanmi Science Co için şu anda hesaplanamaz.
Hanmi Science Co'nin Eulerpool Kalite Puanı 5/10'dur.
Hanmi Science Co'nin ISIN'i KR7008930000'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Hanmi Science Co'nin ticker'ı 008930.KS'dir. Ticker sembolü, Hanmi Science Co hisseleri borsada işlem görmek için kullanılır.
Hanmi Science Co Hissesi
Hanmi Science Co Emsaller Grubu
Hanmi Science Co Ticker
Hanmi Science Co FIGI
Hanmi Science Co'nin tüm temel göstergeleri ve derinlemesine analizi
Hanmi Science Co hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Hanmi Science Co şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: